Market Cap 0.00
Revenue (ttm) 1.36M
Net Income (ttm) -1.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.18%
Debt to Equity Ratio 0.00
Volume 2,000
Avg Vol 9,840
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 0%
Beta 1.54
Analysts Strong Buy
Price Target N/A

Company Profile

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 303-309-0105
Address:
3888 East Mexico Avenue, Suite 202, Denver, United States
Latest News on CANL
No data available.